NEWS

Medtronic Receives CE Mark Approval for the Percept™ PC Neurostimulator...

This Next-Generation DBS Technology Allows Physicians to Review Patient-Specific Brain Signals, Enabling More Personalized, Data-Driven Neurostimulation Treatment for Patients 

Cerebellar AVM with occipital artery and PICA feeding

Medtronic Acquires Stimgenics, Pioneer of DTM™, a Novel Spinal Cord Stim...

Randomized Control Trial Results to be Presented at NANS Jan. 23-26 in Las Vegas; New, Proprietary Differential Target Multiplexed (DTM) Therapy Available on Medtronic Intellis Spinal Cord Stimulation Platform

Dual layer devices: evaluation using oct technology

First transradial robotic carotid stenting in the US

When one door closes another one opens

Philips announces WE-TRUST multicenter clinical trial

Philips announces WE-TRUST multicenter clinical trial to assess impact o...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major clinical trial to assess the impact of a ‘Direct to Angio Suite’ workflow on stroke patient outcomes.

Endovascular Treatment of Brain Aneurysms

LINNC ASIA 2019, the second day